Clinical Trial

A Clinical Trial of HRS-1301 on the Pharmacokinetics of Rosuvastatin Calcium Tablets in Healthy Subjects

Completed Phase 1
View on ClinicalTrials.gov →
Summary
The study was designed to evaluate the pharmacokinetic effects of rosuvastatin calcium tablets after oral administration of HRS-1301 in healthy subjects.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-07-24.
Status change: Not Yet Recruiting → Completed 2026-01-07
Trial Details
NCT Number NCT07097831
Lead Sponsor Shandong Suncadia Medicine Co., Ltd.
Conditions Hyperlipidemia
Enrollment 16 participants
Start Date 2025-10-09
Primary Completion 2025-11-07 (estimated)
Study Completion 2025-11-07 (estimated)
Updated on ClinicalTrials.gov 2026-01-09